Rosuvastatin was evaluated for its ability to prevent vascular events in men and women with elevated C-reactive protein in a 2008 study published in the New England Journal of Medicine.

Authors

• Person: Not available Organization: Frontiers
  Editorial: Inflammation and chronic disease - Frontiers

Sources

• Editorial: Inflammation and chronic disease - Frontiers www.frontiersin.org Frontiers via serper

Referenced by nodes (1)

• C-reactive protein concept